Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Alphy Biotech is a China-based biotechnology and natural ingredients company focused on large-scale cultivation of Haematococcus pluvialis and production of natural astaxanthin. The company supplies commercial astaxanthin ingredients in multiple formats, including algae powder, beadlets, oleoresin, and cold-water-dispersible powder, for nutraceutical, food, and cosmetic applications. It also markets branded personal care ingredients derived from upcycled coffee by-products, including KAFFAGE and KAFFAIR. Alphy appears to operate an integrated in-house manufacturing model from algae culture through downstream processing and positions itself as a major Chinese supplier of natural astaxanthin. Based on available public information, it is a commercial-stage ingredients business rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alphy Biotech.